Sodium phosphate tablets and acute phosphate nephropathy

Am J Gastroenterol. 2009 Aug;104(8):1903-6. doi: 10.1038/ajg.2009.342.

Authors

Ann Corken Mackey¹, Lanh Green, Keith St Amand, Mark Avigan

Affiliation

¹ Office of Surveillance and Epidemiology, Food and Drug Administration, Building 22, Room 3472, 10903 New Hampshire Avenue, Silver Spring, Maryland 20993, USA. ann.mackey@fda.hhs.gov

PMID: 19661931
DOI: 10.1038/ajg.2009.342

No abstract available

MeSH terms

Acute Disease
Adult
Aged
Cathartics / adverse effects*
Female
Humans
Kidney Diseases / chemically induced*
Kidney Diseases / metabolism*
Male
Middle Aged
Phosphates / adverse effects
Phosphates / metabolism*
Tablets

Substances

Cathartics
Phosphates
Tablets
sodium phosphate